| Financial Year |
March 31 2023 |
| Monetary Funds |
667,345,789.89 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
146,639,223.50 |
| Advances to Suppliers |
65,983,661.16 |
| Other Receivables |
251,907.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
224,444,160.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
237,904,463.10 |
| Total Current Assets |
1,543,674,704.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,128,440.57 |
| Investment Properties |
-- |
| Fixed Assetes |
2,534,538,062.68 |
| Under-construction Projects |
6,742,379,330.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
406,608,632.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
12,896,035.39 |
| Other Non-Current Assets |
5,628,462.13 |
| Sub-Total of Non-Current Assets |
9,729,184,783.26 |
| Total Assets |
11,272,859,488.02 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,639,616,579.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,042,329.23 |
| Taxes Payable |
5,033,649.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
362,226,138.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
77,330,128.79 |
| Other Current Liabilities |
3,884,945.42 |
| Sub-Total of Current Liabilities |
2,135,025,468.30 |
| Long-term Loans |
3,774,024,604.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
729,122.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,789,756,854.47 |
| Total Liabilities |
5,924,782,322.77 |
| Paid-In Capital(Or Share Stock) |
1,052,944,789.00 |
| Capital Surplus |
2,245,614,814.43 |
| Surplus Reserve |
157,274,614.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
981,398,053.28 |
| Minority Stockholder's Interest |
865,747,886.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,482,329,279.15 |
| Owner's Equity（Stockholder's Equity） |
5,348,077,165.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,272,859,488.02 |
